BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation announced the availability of the clinical version of the C-SSRS on the SitePad tablet, enabling clinicians and study staff to electronically assess ...
PHILADELPHIA, Jan. 5, 2011 /PRNewswire/ -- ERT (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced that ...
Please provide your email address to receive an email when new articles are posted on . The esketamine group had significantly improved C-SSRS and MADRS scores compared with those receiving midazolam.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results